RMTI Rockwell Medical, Inc.
Stock · NasdaqCM · United States · Healthcare · US7743744093
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Rockwell Medical, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
7.73 USD
+1.71%
52-week range
4.89 – 12.90
Dividend yield—
Market cap31.2M
NowoTrade score
8 Grade A
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:52. Information, not advice.
Results
Next results
12 Nov 2026
in 4 days · 08:00 · estimate -0.18
Last results
-0.40 vs -0.25 estimated
07 May 2026 · Miss -60.0%
Beat the estimate
5 of 12
6 missed · 1 in line
Average surprise
+5.7%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 12 Nov 2026 08:00 | -0.18 | — | — | Upcoming |
| 13 Aug 2026 08:00 | -0.23 | — | — | — |
| 07 May 2026 06:00 | -0.25 | -0.40 | -60.0% | Miss |
| 26 Mar 2026 06:00 | 0.20 | -0.10 | -150.0% | Miss |
| 12 Nov 2025 06:00 | -0.45 | -0.50 | -11.1% | Miss |
| 14 Aug 2025 06:00 | -0.50 | -0.50 | 0.0% | In line |
| 12 May 2025 06:00 | -0.50 | -0.40 | +20.0% | Beat |
| 20 Mar 2025 06:00 | 0.20 | -0.20 | -200.0% | Miss |
| 12 Nov 2024 06:00 | 0.10 | 0.50 | +400.0% | Beat |
| 08 Aug 2024 06:00 | -0.35 | 0.10 | +128.6% | Beat |
| 14 May 2024 06:00 | -0.40 | -0.60 | -50.0% | Miss |
| 21 Mar 2024 06:00 | -0.70 | -0.50 | +28.6% | Beat |
| 14 Nov 2023 06:00 | -0.90 | -0.87 | +3.3% | Beat |
| 14 Aug 2023 06:00 | -1.20 | -1.69 | -41.2% | Miss |
| 15 May 2023 06:00 | -2.80 | -1.00 | +64.3% | Beat |
| 30 Mar 2023 07:00 | -3.90 | -1.40 | +64.1% | Beat |
| 14 Nov 2022 08:00 | -3.70 | -4.00 | -8.1% | Miss |
| 15 Aug 2022 06:00 | -8.10 | -5.60 | +30.9% | Beat |
| 16 May 2022 16:00 | -7.70 | -8.40 | -9.1% | Miss |
| 08 Apr 2022 16:00 | -9.90 | -9.90 | 0.0% | In line |
| 15 Nov 2021 16:00 | -8.25 | -8.80 | -6.7% | Miss |
| 16 Aug 2021 16:00 | -8.80 | -9.90 | -12.5% | Miss |
| 17 May 2021 16:00 | -9.90 | -8.80 | +11.1% | Beat |
| 31 Mar 2021 16:00 | -8.80 | -9.90 | -12.5% | Miss |
| 09 Nov 2020 17:00 | -7.70 | -11.00 | -42.9% | Miss |
| 10 Aug 2020 17:00 | -15.40 | -9.57 | +37.9% | Beat |
| 11 May 2020 16:00 | -13.20 | -13.20 | 0.0% | In line |
| 12 Mar 2020 16:00 | -13.57 | -12.10 | +10.8% | Beat |
| 11 Nov 2019 16:00 | -17.23 | -13.20 | +23.4% | Beat |
| 08 Aug 2019 16:00 | -17.60 | -19.80 | -12.5% | Miss |
| 15 Mar 2018 16:00 | -13.20 | -19.80 | -50.0% | Miss |
| 08 Nov 2017 16:00 | -11.00 | -11.00 | 0.0% | In line |
| 09 Aug 2017 16:00 | -11.00 | -15.40 | -40.0% | Miss |
| 09 May 2017 17:00 | -8.80 | -9.90 | -12.5% | Miss |
| 15 Mar 2017 16:00 | -11.55 | -11.00 | +4.8% | Beat |
| 07 Nov 2016 16:00 | -12.10 | -9.90 | +18.2% | Beat |
| 08 Aug 2016 16:00 | -7.70 | -12.10 | -57.1% | Miss |
| 10 May 2016 17:00 | -13.20 | -11.00 | +16.7% | Beat |
| 29 Feb 2016 16:00 | 2.20 | -13.20 | -700.0% | Miss |
| 10 Nov 2015 06:00 | -4.40 | -5.50 | -25.0% | Miss |
| 04 Aug 2015 17:00 | -10.63 | -5.50 | +48.3% | Beat |
| 07 May 2015 17:00 | -13.93 | -7.70 | +44.7% | Beat |
| 26 Feb 2015 16:00 | -10.45 | -15.40 | -47.4% | Miss |
| 10 Nov 2014 16:00 | -11.00 | -11.00 | 0.0% | In line |
| 31 Jul 2014 16:00 | -14.30 | -8.80 | +38.5% | Beat |
| 12 May 2014 16:00 | -15.40 | -22.00 | -42.9% | Miss |
| 26 Feb 2014 16:00 | -37.40 | -23.10 | +38.2% | Beat |
| 05 Nov 2013 16:00 | -23.65 | -37.40 | -58.1% | Miss |
| 01 Aug 2013 16:00 | -34.10 | -41.80 | -22.6% | Miss |
| 08 May 2013 16:00 | -64.90 | -79.20 | -22.0% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 69.3M | -31.8% | -5.3M | -7.7% | -1.50 | -400.0% | -1.2M |
| 2024 | 101.5M | +21.4% | -480K | -0.5% | -0.30 | +91.9% | 3.2M |
| 2023 | 83.6M | +14.8% | -8.4M | -10.1% | -3.70 | +80.4% | -9.7M |
| 2022 | 72.8M | — | -18.7M | -25.7% | -18.90 | — | -17.2M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 May 2025 | 12.90 | 13.00 | 10.30 | 10.40 | -7.14% | 77,530 | |
| 09 May 2025 | 11.70 | 11.80 | 11.00 | 11.20 | -4.27% | 15,260 | |
| 08 May 2025 | 11.20 | 12.10 | 11.20 | 11.70 | +4.46% | 25,370 | |
| 07 May 2025 | 11.00 | 11.30 | 10.80 | 11.20 | +0.90% | 16,960 | |
| 06 May 2025 | 11.90 | 12.30 | 10.90 | 11.10 | -6.72% | 29,350 | |
| 05 May 2025 | 12.30 | 12.50 | 11.60 | 11.90 | -3.25% | 19,450 | |
| 02 May 2025 | 12.10 | 13.10 | 11.80 | 12.30 | +13.89% | 60,480 | |
| 01 May 2025 | 10.90 | 11.20 | 10.60 | 10.80 | 0.00% | 8,220 | |
| 30 Apr 2025 | 10.60 | 11.00 | 10.50 | 10.80 | -1.82% | 6,650 | |
| 29 Apr 2025 | 11.20 | 11.20 | 10.70 | 11.00 | -2.65% | 12,890 | |
| 28 Apr 2025 | 11.60 | 11.90 | 11.10 | 11.30 | -3.42% | 8,680 | |
| 25 Apr 2025 | 11.80 | 12.00 | 11.40 | 11.70 | -1.68% | 12,680 | |
| 24 Apr 2025 | 11.50 | 12.00 | 11.40 | 11.90 | +3.48% | 13,300 | |
| 23 Apr 2025 | 10.60 | 11.70 | 10.60 | 11.50 | +9.52% | 28,340 | |
| 22 Apr 2025 | 10.40 | 10.50 | 10.10 | 10.50 | +2.94% | 22,430 | |
| 21 Apr 2025 | 10.30 | 10.60 | 10.10 | 10.20 | -0.97% | 9,620 | |
| 17 Apr 2025 | 10.40 | 10.50 | 10.00 | 10.30 | 0.00% | 7,420 | |
| 16 Apr 2025 | 10.20 | 10.60 | 10.20 | 10.30 | -0.96% | 14,180 | |
| 15 Apr 2025 | 10.40 | 10.80 | 10.20 | 10.40 | -0.95% | 22,130 | |
| 14 Apr 2025 | 10.90 | 11.00 | 10.20 | 10.50 | -0.94% | 18,120 | |
| 11 Apr 2025 | 10.60 | 11.10 | 10.40 | 10.60 | -0.93% | 20,890 | |
| 10 Apr 2025 | 10.80 | 11.10 | 10.00 | 10.70 | -3.60% | 32,390 | |
| 09 Apr 2025 | 9.90 | 11.10 | 9.30 | 11.10 | +12.12% | 23,830 | |
| 08 Apr 2025 | 9.70 | 10.60 | 9.70 | 9.90 | +2.06% | 22,970 | |
| 07 Apr 2025 | 9.30 | 10.50 | 8.60 | 9.70 | -3.00% | 42,910 |
Page 16 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Rockwell Medical stock surges on $125M Vantive acquisition deal (opens in a new tab) Investing.com · 03 Nov 2026 15:26
- Rockwell Medical, Inc. (RMTI) M&A Call Transcript (opens in a new tab) SeekingAlpha · 03 Nov 2026 11:16
- Vantive Announces Agreement to Divest Majority of Hemodialysis Assets and Associated Operations to Rockwell Medical (opens in a new tab) 03 Nov 2026 11:01
- Rockwell Medical Announces Transformational Global Hemodialysis Acquisition (opens in a new tab) 03 Nov 2026 11:00
- Rockwell Medical To Acquire Majority Of Vantive's Hemodialysis Business; Terms Not Disclosed (opens in a new tab) Benzinga · 03 Nov 2026 07:04
- Minot Light’s Bullish Stance on Rockwell Medical (RMTI) (opens in a new tab) Insider Monkey · 22 Sep 2026 15:06
- Rockwell Medical (RMTI) Q2 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 14 Aug 2026 03:59
- Rockwell Medical Inc (RMTI) (Q2 2026) Earnings Call Highlights: Revenue Up 11% and Cash Flow ... (opens in a new tab) GuruFocus.com · 14 Aug 2026 00:09
- Rockwell Medical, Inc. Q2 2026 Earnings Call Summary (opens in a new tab) Moby · 13 Aug 2026 18:06
- Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates (opens in a new tab) Zacks · 13 Aug 2026 12:10
- Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (opens in a new tab) Zacks · 06 Aug 2026 15:00
- Rockwell Medical Announces First Reverse Stock Split In 4 Years – Nasdaq Compliance In Focus As Shares Haven’t Traded Above $1 Since March (opens in a new tab) Stocktwits · 29 Jun 2026 12:40
- RMTI Q1 2026 Earnings Transcript (opens in a new tab) Motley Fool · 08 May 2026 16:11
- Rockwell Medical (RMTI) Reports Q1 Loss, Misses Revenue Estimates (opens in a new tab) Zacks · 07 May 2026 12:10
- How The Rockwell Medical (RMTI) Story Is Shifting With Recalibrated Fair Value Targets (opens in a new tab) Simply Wall St. · 28 Apr 2026 18:04
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 7.60 USD
- Market cap
- 31.2M
- Exchange
- NasdaqCM
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 0.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 6.9 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 1.4 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
- Score capped at 60: free cash flow was negative in two of the last three years
- Thin interest cover: operating profit is only -4.2× the interest
- The last full year was a loss
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 12 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | 110.43× | Weak | 14.94× |
| Price / book | 0.88× | Good | 3.81× |
| Price / sales | 0.45× | Good | 3.19× |
| EV / EBITDA | -8.35× | Weak | 12.63× |
| Free cash flow yield | 1.1% | Weak | 2.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 17.7% | Weak | 58.6% |
| Operating margin | -6% | Weak | 7.8% |
| Net margin | -7.3% | Weak | 2.8% |
| Return on equity | -15.5% | Weak | 5.7% |
| Return on assets | -5.2% | Weak | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | -1.7% | Weak | 10.8% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.4× | Good | 0.48× |
| Interest cover | -4.17× | Weak | 2.76× |
| Current ratio | 3.25× | Good | 2.35× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow RMTI and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.